ECA+ Overview
ECA+ is a multi-component stimulant research blend combining ephedrine, caffeine, and acetylsalicylic acid (aspirin), with additional inclusion of 1,3-Dimethylamylamine (DMAA) and Yohimbine HCl. The formulation is discussed in research contexts involving central nervous system stimulation, adrenergic receptor interaction, and metabolic pathway modulation.
Compound Profile
- Category: Multi-stimulant research formulation
- Primary Focus: Adrenergic receptor and CNS pathway interaction
- Status: Experimental compound blend
Label Composition (per capsule)
- Ephedrine – 30 mg
- Caffeine – 250 mg
- Aspirin (Acetylsalicylic Acid) – 150 mg
- 1,3-Dimethylamylamine (DMAA) – 50 mg
- Yohimbine HCl – 3 mg
Key Research Points
- Investigated for combined adrenergic pathway interaction
- Analyzed for thermogenic signaling mechanisms in laboratory models
- Explored for central nervous system stimulant synergy
- Studied for receptor-binding characteristics related to catecholamine pathways
Note: Informational text.